Worldwide and regional prevalence rates of co-occurrence of insomnia and insomnia symptoms with obstructive sleep apnea: A systematic review and meta-analysis

Recent investigations have established that patients with obstructive sleep apnea (OSA) and insomnia have greater daytime impairments and reduced quality of life compared to those with either disorder alone. The present study reviewed current data on the co-occurrence prevalence of insomnia and inso...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sleep medicine reviews Ročník 45; s. 1 - 17
Hlavní autoři: Zhang, Ye, Ren, Rong, Lei, Fei, Zhou, Junying, Zhang, Jihui, Wing, Yun-Kwok, Sanford, Larry D., Tang, Xiangdong
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier Ltd 01.06.2019
Témata:
Adult
Co-occurrence
Comorbidity
Disorders of Excessive Somnolence - epidemiology
Female
Humans
Insomnia
Male
Middle Aged
Obstructive sleep apnea
Prevalence
Severity of Illness Index
Sleep Apnea Syndromes - epidemiology
Sleep Apnea, Obstructive - epidemiology
Sleep Initiation and Maintenance Disorders - epidemiology
Prevalence
Insomnia
Obstructive sleep apnea
Co-occurrence
ISSN:1087-0792, 1532-2955, 1532-2955
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Recent investigations have established that patients with obstructive sleep apnea (OSA) and insomnia have greater daytime impairments and reduced quality of life compared to those with either disorder alone. The present study reviewed current data on the co-occurrence prevalence of insomnia and insomnia symptoms with OSA and assessed its worldwide and regional prevalence based on World Health Organization (WHO) regions. A total of 37 studies were included in the analysis. The overall prevalence rates of insomnia, any insomnia complaints, difficulty falling asleep (DFA), difficulty maintaining sleep (DMS) and early morning awakening (EMA) found in OSA patients were 38%, 36%, 18%, 42%, and 21%, respectively. According to the regional classification of the WHO, the rates of DFA, DMS and EMA in OSA patients in the Western Pacific Region were lower than those in the European Region and the Region of the Americas. We also analyzed the pooled prevalence rates of OSA based on different apnea-hypopnea index (AHI) criteria in insomnia patients. The rates were 35% (AHI≥5) and 29% (AHI≥15), respectively. Regional differences of DFA, DMS and EMA in OSA patients may be related to sex, age and body mass index.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:1087-0792
1532-2955
1532-2955
DOI:10.1016/j.smrv.2019.01.004